Correct answer = B. Dabigatran.
Dabigatran is only approved for the prevention of stroke in nonvalvular atrial fibrillation; it is not approved for the treatment of acute DVT. All of the other options are approved for treatment of acute DVT.
Read More about Anticoagulants and Fibrinolytics